Vaccines against Antimicrobial-Resistant Infections
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 8674
Interests: human viruses; delivery systems; vaccines; preclinical development; immune metabolisms
Special Issues, Collections and Topics in MDPI journals
The worldwide increase in diseases caused by antibiotic-resistant bacteria due to overuse and misuse of antibiotics presents an alarming concern for public health. Antibiotic resistance, which is genetically transmitted and diffused among bacteria species, arises each time a new drug is introduced into clinical practice, and the spread of multi-drug resistant bacteria from animals to humans can occur frequently. Antibiotics are therefore insufficient to control the morbidity and mortality associated with infectious diseases. The development of new vaccines both for veterinary and human use appears to be a promising way to prevent or stop the spread of antibiotic-resistant infections. Also, increasing evidence indicates that vaccination can reduce the increase in antibiotic-resistant strain development by decreasing the need for the use of antibiotics. Newly developed technologies and adjuvants make it possible to generate vaccines against virtually every pathogen, thus offering an effective solution to the problem of antibiotic resistance.
This Special Issue aims to present an extensive overview of the latest scientific knowledge on, and current state-of-the-art vaccines against, antibiotic-resistant infections such as those included in the list of antibiotic-resistant “priority pathogens” published by WHO. We invite authors to contribute original reports, original observations, or reviews that address this major public health emergency.
Dr. Aldo Tagliabue
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.